Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaoru Tsuchiya

Showing results (121-130 of 149) with videos related to

Pageof 15
Sort By:
Cancers|October 12, 2019
Sorafenib-Regorafenib Sequential Therapy in Japanese Patients with Unresectable Hepatocellular Carcinoma-Relative Dose Intensity and Post-Regorafenib Therapies in Real World PracticeWan Wang, Kaoru Tsuchiya, Masayuki Kurosaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 27, 2017
Up-to-seven criteria as a useful predictor for tumor downstaging to within Milan criteria and Child-Pugh grade deterioration after initial conventional transarterial chemoembolizationYutaka Yasui, Kaoru Tsuchiya, Masayuki Kurosaki, et al.
Journal of Gastroenterology and Hepatology|March 18, 2024
Impact of immune-related adverse events in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumabKeito Suzuki, Yutaka Yasui, Kaoru Tsuchiya, et al.
Cancers|February 11, 2023
Clinical Utility of Comprehensive Genomic Profiling in Patients with Unresectable Hepatocellular CarcinomaShun Ishido, Kaoru Tsuchiya, Yoshihito Kano, et al.
Digestive Diseases (Basel, Switzerland)|August 4, 2021
Plasma Renin Activity Predicts Prognosis and Liver Disease-Related Events in Liver Cirrhosis Patients with Ascites Treated by TolvaptanLeona Osawa, Hiroyuki Nakanishi, Masayuki Kurosaki, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|May 23, 2022
Conversion surgery for hepatocellular carcinoma after tyrosine kinase inhibitor treatmentShun Kaneko, Kaoru Tsuchiya, Yutaka Yasui, et al.
Antiviral Therapy|August 6, 2011
Relationship between polymorphisms of the inosine triphosphatase gene and anaemia or outcome after treatment with pegylated interferon and ribavirinMasayuki Kurosaki, Yasuhito Tanaka, Keisuke Tanaka, et al.
Cancers|July 27, 2022
Clinical Usefulness of Monitoring Muscle Volume during Atezolizumab Plus Bevacizumab Therapy in Patients with Unresectable Hepatocellular CarcinomaHiroaki Matsumoto, Kaoru Tsuchiya, Hiroyuki Nakanishi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 14, 2020
Strategy for advanced hepatocellular carcinoma based on liver function and portal vein tumor thrombosisShun Kaneko, Kaoru Tsuchiya, Yutaka Yasui, et al.
Scientific Reports|August 13, 2020
Impaired brain function improved by L-carnitine in patients with cirrhosis: evaluation using near-infrared spectroscopyHiroyuki Nakanishi, Yuka Hayakawa, Youhei Kubota, et al.
Pageof 15

Showing results (121-130 of 149) with videos related to

Sort By:
Pageof 15
Cancers|October 12, 2019
Sorafenib-Regorafenib Sequential Therapy in Japanese Patients with Unresectable Hepatocellular Carcinoma-Relative Dose Intensity and Post-Regorafenib Therapies in Real World PracticeWan Wang, Kaoru Tsuchiya, Masayuki Kurosaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 27, 2017
Up-to-seven criteria as a useful predictor for tumor downstaging to within Milan criteria and Child-Pugh grade deterioration after initial conventional transarterial chemoembolizationYutaka Yasui, Kaoru Tsuchiya, Masayuki Kurosaki, et al.
Journal of Gastroenterology and Hepatology|March 18, 2024
Impact of immune-related adverse events in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumabKeito Suzuki, Yutaka Yasui, Kaoru Tsuchiya, et al.
Cancers|February 11, 2023
Clinical Utility of Comprehensive Genomic Profiling in Patients with Unresectable Hepatocellular CarcinomaShun Ishido, Kaoru Tsuchiya, Yoshihito Kano, et al.
Digestive Diseases (Basel, Switzerland)|August 4, 2021
Plasma Renin Activity Predicts Prognosis and Liver Disease-Related Events in Liver Cirrhosis Patients with Ascites Treated by TolvaptanLeona Osawa, Hiroyuki Nakanishi, Masayuki Kurosaki, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|May 23, 2022
Conversion surgery for hepatocellular carcinoma after tyrosine kinase inhibitor treatmentShun Kaneko, Kaoru Tsuchiya, Yutaka Yasui, et al.
Antiviral Therapy|August 6, 2011
Relationship between polymorphisms of the inosine triphosphatase gene and anaemia or outcome after treatment with pegylated interferon and ribavirinMasayuki Kurosaki, Yasuhito Tanaka, Keisuke Tanaka, et al.
Cancers|July 27, 2022
Clinical Usefulness of Monitoring Muscle Volume during Atezolizumab Plus Bevacizumab Therapy in Patients with Unresectable Hepatocellular CarcinomaHiroaki Matsumoto, Kaoru Tsuchiya, Hiroyuki Nakanishi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 14, 2020
Strategy for advanced hepatocellular carcinoma based on liver function and portal vein tumor thrombosisShun Kaneko, Kaoru Tsuchiya, Yutaka Yasui, et al.
Scientific Reports|August 13, 2020
Impaired brain function improved by L-carnitine in patients with cirrhosis: evaluation using near-infrared spectroscopyHiroyuki Nakanishi, Yuka Hayakawa, Youhei Kubota, et al.
Pageof 15